Filter Publications

About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.

  • Released: January 13, 2004
    The report is the culmination of a series that offers the most comprehensive examination to date of the consequences of lack of health insurance on individuals, their families, communities and the whole society. The principles to guide health finance reform that are recommended in this sixth and final report of the series are based on the evidence reviewed in the Committee's previous five reports and on new analyses of past and present federal, state, and local efforts to reduce uninsurance.
  • Released: December 19, 2003
    In its fifth letter report, the Committee on Smallpox Vaccination Program Implementation makes several recommendations to the Centers for Disease Control and Prevention related to the draft smallpox readiness indicators (part of a larger set of public health emergency preparedness indicators), scenarios for testing the relevance of the smallpox readiness indicators, and selected aspects of the overall smallpox preparedness and vaccination program.
  • Released: December 11, 2003
    According to a new FNB report, titled Dietary Reference Intakes: Guiding Principles for Nutrition Labeling and Fortification, government authorities in the United States and Canada should use the current Dietary Reference Intake values (DRIs) to update nutrition information on food and dietary supplement labels so that consumers can compare products more easily and make informed food choices based on the latest science.
  • Released: November 20, 2003
    The IOM released Patient Safety: Achieving a New Standard for Care, a report that describes a detailed plan to facilitate the development of data standards applicable to the collection, coding, and classification of patient safety information. This report describes a detailed plan to facilitate the development of data standards applicable to the collection, coding, and classification of patient safety information.
  • Released: November 17, 2003
    In Advancing Prion Science, the IOM Committee on Transmissible Spongiform Encephalopathies: Assessment of Relevant Science recommends priorities for research and investment to the Department of Defense's National Prion Research Program (NPRP). Transmissible spongiform encephalopathies (TSEs), also called prion diseases, are invariably fatal neurodegenerative infectious diseases that include bovine spongiform encephalopathy (commonly called mad cow disease), chronic wasting disease, Creutzfeldt-Jakob disease, and scrapie. Unlike all other known infectious diseases, TSE infectivity appears to be associated with an abnormally folded protein called a prion. To develop antemortem diagnostics or therapies for TSEs, the committee concludes, NPRP should invest in basic research specifically to elucidate the structural features of prions, the molecular mechanisms of prion replication, the mechanisms of TSE pathogenesis, and the physiological function of prions’ normal cellular isoform.
  • Released: November 12, 2003
    Individuals and communities today face many health problems that can be associated with our environment, including waste, unhealthy buildings, suburban sprawl, air pollution, water pollution, and environmentally related stress. At the workshop Rebuilding the Unity of Health and the Environment: A New Vision for the 21st Century, participants explored the need for a broader perspective of environmental health, one that incorporates the natural, the built, and the social environments. This workshop discussed many of the challenges that members of the environmental health community are facing and stressed the need for engaging nontraditional partnerships in addressing these issues.
  • Released: November 11, 2003
    Testosterone has been approved by the Food and Drug Administration for treating a limited number of conditions, particularly male hypogonadism, a clinical condition marked by, but not defined solely by, inadequate testosterone production. Testosterone and Aging: Clinical Research Directions assesses what is currently known about the beneficial and adverse health effects of testosterone therapy in older men and provides recommendations regarding clinical trials of this therapy, including the parameters that should be considered in study design and conduct.
  • Released: November 11, 2003
    This report is a summary of the national workshop in , DC in March 2002. The report summarizes the findings of the IOM study Calling the Shots, reviews the status of implementation of the IOM report recommendations at the federal and state levels, and highlights continuing challenges in immunization finance for the nation as a whole and for individual state and local health departments.
  • Released: November 07, 2003
    In response to a congressional mandate, an IOM committee was formed to reevaluate whether CARE allocation strategies are an equitable and efficient way of distributing resources to jurisdictions with the greatest needs and to assess whether quality of care can be refined and expanded.
  • Released: November 05, 2003
    Each year in the U.S., more than 440,000 babies are born too soon (preterm). Compared with a full-term baby, one born too soon has a much greater chance of dying, having breathing problems, or suffering lifelong medical complications such as cerebral palsy, visual and hearing disabilities, and mental retardation. Although vast improvements have been made in treating premature infants, thus far there has been little success in understanding and preventing prematurity. This workshop built on previous research, and focused on the role of environmental toxins, an area often overlooked, as a risk factor for delivering a preterm infant.